While the increasing volume of clinical data is welcome in many respects, clinicians and trial managers often struggle w...
Over the past decade, the Asia-Pacific (APAC) region has emerged as a global leader in clinical trial conduct. In 2021, ...
The APAC region continues to rule the roost in clinical trials, experiencing dramatic growth rates surpassing those in t...
Australian Translational Genomics Centre (ATGC) at Queensland University of Technology (QUT) will help link Queensland...
A team of healthcare professionals has received a $50,000 award to transform their idea for an Artificial Intelligence (...
ClinChoice, a global Contract Research Organisation (CRO), has announced expanding its global footprint with the acquisi...
The Coalition for Epidemic Preparedness Innovations (CEPI), the Republic of Korea-based International Vaccine Institute ...
US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration ...
An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as...
According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
Singapore-based startup Hummingbird Bioscience has entered into a clinical trial collaboration and supply agreement with...
How do you define the essentials of a decentralised approach in the current drug discovery landscape? It is essential t...
Omi Medical Center, a part of the Seikoukai Social Medical Corporation and one of Japan's leading institu...
In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian Contract ...
Australian biotech firm Vaxxas has announced the initiation of a Phase I clinical trial with the first inactivated ...
